Baloxavir marboxil
Baloxavir marboxil (pronunciation: ba-LOX-a-vir mar-BOX-il) is an antiviral drug used for the treatment of influenza in patients who have been symptomatic for no more than 48 hours. It is marketed under the brand name Xofluza.
Etymology
The name "Baloxavir marboxil" is derived from its chemical structure. "Baloxavir" is a combination of parts of the names of the chemical groups involved in its structure, while "marboxil" indicates that it is a prodrug that is metabolized into its active form in the body.
Pharmacology
Baloxavir marboxil works by inhibiting the endonuclease activity of the polymerase acidic protein, an enzyme that is essential for the replication of the influenza virus. This prevents the virus from multiplying, thereby reducing the duration of flu symptoms.
Usage
Baloxavir marboxil is taken orally, and is typically prescribed as a single dose. It can be used in adults and children aged 12 years and older who have been symptomatic for no more than 48 hours.
Side Effects
Common side effects of Baloxavir marboxil include diarrhea, bronchitis, common cold symptoms, headache, and nausea.
Related Terms
External links
- Medical encyclopedia article on Baloxavir marboxil
- Wikipedia's article - Baloxavir marboxil
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski